adenosine diphosphate has been researched along with Disease Exacerbation in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aryal, N; Asher, R; Berton, D; Colombo, N; Freimund, AE; Frenel, JS; Huzarski, T; Kim, JW; Korach, J; Ledermann, JA; Lee, CK; Oza, AM; Park-Simon, TW; Pautier, P; Penson, RT; Pignata, S; Pujade-Lauraine, E; Sonke, GS; Tamura, K; Vidal, L | 1 |
| Boban, M; Bobana, MD; Cvetkovic, T; Deljanin-Ilic, M; Djindjic, B; Ilic, S; Jevtovic-Stoimenov, T; Kocic, G; Pavlovic, R; Radenkovic, S; Sokolovic, D; Stojanovic, D | 1 |
| Luo, D; Wang, L; Xu, P; Yan, X; Zhang, L; Zheng, Y; Zhu, Z | 1 |
| Aalto, K; Hakovirta, H; Hollmén, M; Jalkanen, J; Jalkanen, S; Kiviniemi, T; Salomaa, V; Yegutkin, GG | 1 |
| Dai, J; Houard, X; Louedec, L; Michel, JB; Philippe, M | 1 |
| Elima, K; Jalkanen, S; Karikoski, M; Laurila, JP; Marttila-Ichihara, F; Niemelä, J; Salmi, M; Yegutkin, GG | 1 |
| Curiel, TJ; Fan, J; Shin, T; Thompson, LF; Wang, L; Zhang, B; Zhang, Y | 1 |
| Day, SM; Duquaine, D; Fay, WP; Khan, BV; Menon, RG; Mundada, LV; Rajagopalan, S | 1 |
| Cosi, C; Fluit, P; Gallo-Hendrikx, E; Marien, MR; Martel, JC; Mount, HT; Wu, Y | 1 |
| Cha, JK; Jeon, HW | 1 |
| Colgan, SP; Karhausen, J; Louis, NA; MacManus, CF; Robinson, AM; Scully, M | 1 |
| Kähönen, M; Pörsti, I; Sallinen, K; Tolvanen, JP; Wu, X | 1 |
| Ballmaier, M; Cherkaoui, K; Eilers, M; Gaudig, A; Germeshausen, M; Krukemeier, S; Lang, S; Schulze, H; Strauss, G; Welte, K | 1 |
| Borg, J; Lampert, E; Leclerc, N; Poindron, P; Ribera, F; Warter, JM; Zoll, J | 1 |
| Chen, CJ; Chen, SY; Chen, WY; Chiang, AN; Kao, TK; Liao, SL; Ou, YC; Wang, CC | 1 |
1 trial(s) available for adenosine diphosphate and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Topics: Adenosine Diphosphate; Antineoplastic Agents; BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Disease Progression; Female; Humans; Maintenance Chemotherapy; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
14 other study(ies) available for adenosine diphosphate and Disease Exacerbation
| Article | Year |
|---|---|
Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Blood Pressure; Creatinine; Disease Progression; Essential Hypertension; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Renal Dialysis; Urea; Uric Acid; Xanthine Dehydrogenase; Xanthine Oxidase | 2014 |
Altered platelet calsequestrin abundance, Na⁺/Ca²⁺ exchange and Ca²⁺ signaling responses with the progression of diabetes mellitus.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Calcium Signaling; Calcium-Binding Proteins; Calsequestrin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Progression; Down-Regulation; Male; Platelet Aggregation; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; Streptozocin; Time Factors | 2014 |
Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Triphosphate; Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Angiotensin-Converting Enzyme Inhibitors; Antigens, CD; Apyrase; Artifacts; Atherosclerosis; Biomarkers; Chronic Disease; Comorbidity; Disease Progression; Drug Utilization; Female; Finland; GPI-Linked Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoxia; Male; Middle Aged; Models, Cardiovascular; Peripheral Arterial Disease; Purinergic P2Y Receptor Antagonists; Risk Factors; Second Messenger Systems; Smoking; Thrombophilia | 2015 |
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.
Topics: Adenosine; Adenosine Diphosphate; Animals; Aorta; Aortic Aneurysm, Abdominal; Blood Platelets; Disease Models, Animal; Disease Progression; Elastic Tissue; Guinea Pigs; Inflammation; Male; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred Lew; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Time Factors; Transplantation, Heterologous | 2009 |
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Triphosphatases; Animals; Apyrase; Cell Proliferation; Disease Progression; Interferon-gamma; Lectins, C-Type; Lymphocytes; Lymphocytes, Tumor-Infiltrating; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Nitric Oxide Synthase Type II; Purines; Receptors, Cell Surface; RNA, Messenger; Signal Transduction; T-Lymphocytes, Regulatory | 2011 |
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Chemotaxis, Leukocyte; Disease Progression; Female; Immunotherapy, Adoptive; Lymphocytes, Tumor-Infiltrating; Lymphoma, Non-Hodgkin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Molecular Targeted Therapy; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Chimera; Second Messenger Systems; T-Lymphocytes; T-Lymphocytes, Regulatory; Tumor Burden | 2011 |
Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Carotid Arteries; Carotid Artery Thrombosis; Cysteine; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Free Radical Scavengers; Iron; Iron Overload; Iron-Dextran Complex; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Platelet Aggregation; Reactive Oxygen Species; Thromboplastin; Time; Vascular Patency; Vasodilation; Vasodilator Agents | 2003 |
Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Catecholamines; Cell Cycle Proteins; Cerebellum; Corpus Striatum; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Dopamine; Mesencephalon; Mice; Mice, Knockout; NAD; NADP; Protein Serine-Threonine Kinases; Psychomotor Performance; Sex Factors; Tumor Suppressor Proteins | 2004 |
Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; Disease Progression; Female; Humans; Infarction, Middle Cerebral Artery; Logistic Models; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2008 |
Control of IFN-alphaA by CD73: implications for mucosal inflammation.
Topics: 5'-Nucleotidase; Acute Disease; Adenosine Diphosphate; Animals; Colitis; Disease Progression; Down-Regulation; Inflammation Mediators; Interferon-alpha; Interleukin-10; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Messenger; Trinitrobenzenesulfonic Acid | 2008 |
Influence of gender on control of arterial tone in experimental hypertension.
Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic beta-Agonists; Animals; Apamin; Blood Pressure; Calcium; Diclofenac; Disease Progression; Endothelium, Vascular; Female; Hypertension; In Vitro Techniques; Isoproterenol; Male; Mesenteric Artery, Superior; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroprusside; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin; Sex Characteristics; Vasoconstriction | 1998 |
c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
Topics: Adenosine Diphosphate; Blood Platelets; Child; Child, Preschool; Colony-Forming Units Assay; Disease Progression; DNA Mutational Analysis; Female; Genotype; Hematopoietic Stem Cells; Humans; Infant; Male; Megakaryocytes; Mutation; Neoplasm Proteins; Pancytopenia; Phosphorylation; Platelet Activation; Prognosis; Proto-Oncogene Proteins; Receptors, Cytokine; Receptors, Thrombopoietin; Signal Transduction; Thrombocytopenia; Thrombopoietin | 2001 |
Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice.
Topics: Adenosine Diphosphate; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Brain; Cell Respiration; Diaphragm; Disease Models, Animal; Disease Progression; Enzyme Activation; Glycolysis; Humans; Mice; Mice, Transgenic; Mitochondria, Muscle; Muscle, Skeletal; Organ Specificity; Oxidation-Reduction; Oxidative Phosphorylation; Oxygen Consumption; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2001 |
Opioids modulate post-ischemic progression in a rat model of stroke.
Topics: Amidines; Analgesics, Opioid; Animals; Benzamides; Brain; Brain Ischemia; Cytoprotection; Disease Models, Animal; Disease Progression; Dynorphins; Encephalitis; Immune Tolerance; Interleukin-6; Male; Narcotic Antagonists; Neuroprotective Agents; Peptide Fragments; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Stroke | 2008 |